Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer

BACKGROUND: Cancer neoantigens are important targets of cancer immunotherapy and neoantigen vaccines are currently in development in pancreatic ductal adenocarcinoma (PDAC) and other cancer types. Immune regulatory mechanisms in pancreatic cancer may limit the efficacy of neoantigen vaccines. Target...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hui, Li, Lijin, Zuo, Chong, Chen, Michael Y., Zhang, Xiuli, Myers, Nancy B., Hogg, Graham D., DeNardo, David G., Goedegebuure, S. Peter, Hawkins, William G., Gillanders, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772034/
https://www.ncbi.nlm.nih.gov/pubmed/36569934
http://dx.doi.org/10.3389/fimmu.2022.1039226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772034/
https://www.ncbi.nlm.nih.gov/pubmed/36569934
http://dx.doi.org/10.3389/fimmu.2022.1039226

Ejemplares similares